Biotech

All Articles

Amgen documents initial stage 3 gain for $400M eczema medicine

.Amgen has actually discussed (PDF) the initial phase 3 data on its own $400 million eczema medicati...

Biogen, UCB file stage 3 lupus win after stopping working earlier trial

.Biogen as well as UCB's gamble on advancing right into period 3 on the back of a broken research se...

Aptadir hopes brand-new RNA preventions can reverse challenging cancers

.Italian biotech Aptadir Rehabs has actually released with the guarantee that its own pipe of precli...

Wave surfs DMD excellence to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has actually fulfilled its own goal in a Duchenne muscular dystrophy (DMD) study...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer...

Achilles splashes tissue treatment plan, prepares for layoffs after missing 'office viability' goals

.Achilles Therapeutics has actually wrecked its approach. The British biotech is actually knocking o...

Aligos trumpets period 2 MASH succeed, lowering liver excess fat as much as 46%

.Aligos Therapies is actually declaring a midstage succeed in metabolic-dysfunction connected steato...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating new antifungals has acquired a substantial boost coming from t...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing actually scooped up the united state rights to Capricor Therapeutics' late-stage Duchenn...

FDA fragments adcomm for Applied's uncommon illness medicine

.After dismissing the decision date for Applied Therapeutics' metabolic disorder drug govorestat, th...